MR编号 | HU/H/0342/001 |
---|
药品名称 | Co-Dalnessa 2 mg/0,625mg/5mg |
---|
活性成分 | - amlodipine besilate 5.0 mg
- indapamide 0.62 mg
- perindopril tert-butylamine 2.0 mg
|
---|
剂型 | Tablet |
---|
上市许可持有人 | Krka, d.d., Novo mesto |
---|
参考成员国 - 产品名称 | Hungary (HU) Co-Dalnessa 2 mg/0,625mg/5mg tabletta |
---|
互认成员国 - 产品名称 | - Poland (PL)
Co-Amlessa - Lithuania (LT)
Co-Amlessa 2 mg/5 mg/0,625 mg tabletės - Estonia (EE)
CO-DALNESSA - Bulgaria (BG)
Co-Amlessa - Romania (RO)
Co-Amlessa 2 mg/ 0.625 mg/ 5 mg comprimate - Slovakia (SK)
Co-Amlessa 2 mg/5 mg/0,625 mg tablety - Czechia (CZ)
Amlecombi 2 mg/ 0.625 mg/ 5 mg tablety - Slovenia (SI)
- Latvia (LV)
Co-Amlessa 2 mg/5 mg/0,625 mg tabletes
|
---|
许可日期 | 2013/10/23 |
---|
最近更新日期 | 2024/07/03 |
---|
药物ATC编码 | - C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|